WAYMADE-NAPROXEN SODIUM 275 MG — DIN 02463695
NAPROXEN SODIUM : 275 MG · WAYMADE PLC · TABLET · wholesale supply in Canada
Health Canada status: APPROVED
What is WAYMADE-NAPROXEN SODIUM?
WAYMADE-NAPROXEN SODIUM 275 MG contains NAPROXEN SODIUM : 275 MG. It is listed in the Health Canada Drug Product Database under DIN 02463695, held by WAYMADE PLC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 04-May-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Naproxen cost around the world?
Naproxen is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 8 | 74 | USD███.██ |
| South Africa | single exit price | 16 | 25 | ZAR███.██ |
| Sweden | AIP (pharmacy purchase price) | 9 | 24 | SEK███.██ |
| Australia | ex-manufacturer | 8 | 23 | AUD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 8 | 16 | EUR███.██ |
| Saudi Arabia | public | 11 | 14 | SAR███.██ |
| Bahrain | retail (max) | 5 | 9 | BHD███.██ |
| United Arab Emirates | public | 5 | 6 | AED███.██ |
| Iceland | max wholesale | 5 | 5 | ISK███.██ |
| Luxembourg | reimbursement | 5 | 5 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 2 | 4 | CZK███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Hungary | producer price (ex-factory) | 4 | 4 | HUF███.██ |
| Romania | max producer price | 4 | 4 | RON███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Belgium | public | 2 | 2 | EUR███.██ |
222 pack listings across 99 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Naproxen pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Naproxen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
28 holders have a Canadian DIN containing Naproxen, across 125 DINs, of which 31 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 17 | 8 | NTP-NAPROXEN, NTP-NAPROXEN EC, NTP-NAPROXEN SODIUM, NTP-NAPROXEN SODIUM DS, TEVA-NAPROXEN, +4 more | Sourceable in Canada |
| APOTEX INC | 13 | 8 | APO NAPROXEN TAB 125MG, APO-NAPRO-NA, APO-NAPRO-NA DS, APO-NAPROXEN, APO-NAPROXEN EC, +5 more | Sourceable in Canada |
| BAYER INC | 5 | 5 | ALEVE BACK AND BODY PAIN, ALEVE CAPLETS, ALEVE LIQUID GELS, ALEVE NIGHTTIME, MAXIDOL LIQUID GELS | Sourceable in Canada |
| SEARCHLIGHT PHARMA INC | 5 | 4 | ANAPROX, ANAPROX DS, NAPROSYN | Sourceable in Canada |
| PRO DOC LIMITEE | 8 | 3 | NAPROXEN - 250, NAPROXEN - 500, NAPROXEN 125 TAB 125MG, NAPROXEN-375, NAPROXEN-NA, +3 more | Sourceable in Canada |
| PHARMASCIENCE INC | 6 | 2 | NAPROXEN, NAPROXEN LIQUID GELS, NAPROXEN MENSTRUAL PAIN RELIEF, PMS-NAPROXEN, PMS-NAPROXEN EC | Sourceable in Canada |
| MEDEXUS PHARMACEUTICALS INC. | 1 | 1 | PEDIAPHARM NAPROXEN SUSPENSION | Sourceable in Canada |
| SYNTEX INC. | 10 | 0 | ANAPROX, ANAPROX DS TAB 550MG, NAPROSYN 250MG, NAPROSYN 375MG, NAPROSYN E TAB 250MG, +5 more | No marketed DIN |
| NU-PHARM INC | 9 | 0 | NU-NAPRO-NA, NU-NAPRO-NA DS, NU-NAPROX EC, NU-NAPROX TAB 125MG, NU-NAPROX TAB 250MG, +2 more | No marketed DIN |
| SANIS HEALTH INC | 8 | 0 | NAPROXEN, NAPROXEN EC, NAPROXEN SODIUM, NAPROXEN SODIUM DS | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 7 | 0 | RATIO-NAPROXEN, RATIO-NAPROXEN E | No marketed DIN |
| LABORATOIRE RIVA INC. | 5 | 0 | RIVA-NAPROXEN, RIVA-NAPROXEN SODIUM, RIVA-NAPROXEN SODIUM DS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 275 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Naproxen |
|---|---|
| ATC code | M01AE02 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02463695 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2463695 |
| Brand name | WAYMADE-NAPROXEN SODIUM |
| Generic / active ingredient | NAPROXEN SODIUM : 275 MG |
| Market authorization holder | WAYMADE PLC |
| Health Canada schedule | Prescription |
| ATC code | M01AE02 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01AE |
| Current status | APPROVED |
| Status date | 04-May-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
31 of 125 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALEVE BACK AND BODY PAIN | 220 MG | CAPSULE | BAYER INC | MARKETED | 02436337 |
| ALEVE CAPLETS | 220 MG | TABLET | BAYER INC | MARKETED | 02301733 |
| ALEVE LIQUID GELS | 220 MG | CAPSULE | BAYER INC | MARKETED | 02361795 |
| ALEVE NIGHTTIME | 220 MG | TABLET | BAYER INC | MARKETED | 02444593 |
| ANAPROX | 275 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | 02162725 |
| ANAPROX DS | 550 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | 02162717 |
| APO-NAPRO-NA | 275 MG | TABLET | APOTEX INC | MARKETED | 00784354 |
| APO-NAPRO-NA DS | 550 MG | TABLET | APOTEX INC | MARKETED | 01940309 |
| APO-NAPROXEN | 375 MG | TABLET | APOTEX INC | MARKETED | 00600806 |
| APO-NAPROXEN | 250 MG | TABLET | APOTEX INC | MARKETED | 00522651 |
2 · Same class — other molecules in ATC M01AE
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ibuprofen | ACTIPROFEN - CAPLET 200MG · ADVIL 12 HOUR · ADVIL ARTHRITIS PAIN · ADVIL CAPLETS · +107 more | 143 | 46 | Yes |
| Naproxen | ALEVE BACK AND BODY PAIN · ALEVE CAPLETS · ALEVE LIQUID GELS · ALEVE NIGHTTIME · +81 more | 125 | 31 | Yes |
| Ibuprofen, Combinations | ADVIL COLD & FLU · ADVIL COLD & SINUS CONVENIENCE PACK · ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS · ADVIL COLD & SINUS LIQUI-GELS · +36 more | 40 | 13 | Yes |
| Naproxen And Esomeprazole | MYLAN-NAPROXEN/ESOMEPRAZOLE MR · VIMOVO | 4 | 4 | Yes |
| Ketoprofen | KETOPROFEN · KETOPROFEN SR · KETOPROFEN SUPPOSITORIES · KETOPROFEN-E · +28 more | 36 | 3 | Yes |
| Tiaprofenic Acid | ALBERT TIAFEN SR · ALBERT TIAFEN TAB 200MG · ALBERT TIAFEN TAB 300MG · APO-TIAPROFENIC TABLETS -300MG · +15 more | 25 | 2 | Yes |
| Flurbiprofen | ANSAID TABLETS 100 MG · ANSAID TABLETS 50 MG · FLURBIPROFEN · FLURBIPROFEN-100 TAB 100MG · +12 more | 19 | 2 | Yes |
| Oxaprozin | APO-OXAPROZIN · DAYPRO · RHOXAL-OXAPROZIN | 3 | 0 | Not in Canada |
| Fenoprofen | NALFON CAP 300MG · NALFON TAB 600MG | 2 | 0 | Not in Canada |
| Naproxen And Diphenhydramine | PAIN RELIEVER & SLEEP AID | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M01AB | Diclofenac · Diclofenac, Combinations · Etodolac · Indometacin · Ketorolac · +2 more | 170 | 38 |
| M01AH | Celecoxib · Rofecoxib | 72 | 30 |
| M01AC | Meloxicam · Piroxicam · Tenoxicam | 67 | 14 |
| M01AG | Mefenamic Acid | 7 | 1 |
| M01AX | Nabumetone | 12 | 1 |
| M01AA | Oxyphenbutazone · Phenylbutazone · Phenylbutazone, Combinations | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is WAYMADE-NAPROXEN SODIUM called?
The same molecule, Naproxen, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Naproxen Bluefish | Latin | Sweden |
| Pronaxen® | Latin | Sweden |
| Napflam | Latin | South Africa |
| Naprosyn | Latin | Australia, South Africa |
| NAROX | Latin | Bahrain |
| Crysanal | Latin | Australia |
| Naproxen Evolan | Latin | Sweden |
| Adco-Naproxen | Latin | South Africa |
| EMOXEN PLUS | Latin | Czechia |
| Nafasol Ec | Latin | South Africa |
| NALGESIN | Latin | Czechia |
| Naprocur | Latin | Sweden |
| Naprosyn® Entero | Latin | Sweden |
| Naproxen Orifarm | Latin | Sweden |
| Phebra Naproxen Suspension | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.